Nicholas J. Diamond, JD, LLM, MBe is an advisor and interdisciplinary academic. His expertise focuses on public health law, public international law, and international investment law.
At Avalere, an advisory firm in Washington, DC, Nick provides strategic counsel to biopharmaceutical companies and others in the health sector on public policy, government affairs, and market access issues. His work has spanned therapeutic areas and all levels of government. In prior roles, he led global market strategy for the health sector at a Silicon Valley technology company, as well as advised the U.S. government on public policy issues during implementation of the Affordable Care Act.
Nick is an adjunct professor of law at Georgetown Law and an associate scholar in the Center for Global Health at the University of Pennsylvania. He is also a PhD candidate in public international law at Leiden Law School, where he is writing on human rights considerations in international investment law. His other academic engagement includes serving: on the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO); as a contributor to Oxford University Press’ Investment Claims resource; and as a contributor to Harvard Law School’s Bill of Health blog. In the past, he has: taught at The George Washington University (2016-19) and Drexel University (2013-14); and served as an adjunct fellow in the University of Pennsylvania’s Center for Public Health Initiatives (2016-19).
Nick’s work has appeared in law reviews, peer-reviewed journals, and popular media outlets. He has lectured in various academic and industry fora, as well as appeared on U.S. news programs as an expert in public health law. He trained as a lawyer in the U.S., and holds graduate degrees in global health law and bioethics. He resides in Washington, DC.
At Avalere, an advisory firm in Washington, DC, Nick provides strategic counsel to biopharmaceutical companies and others in the health sector on public policy, government affairs, and market access issues. His work has spanned therapeutic areas and all levels of government. In prior roles, he led global market strategy for the health sector at a Silicon Valley technology company, as well as advised the U.S. government on public policy issues during implementation of the Affordable Care Act.
Nick is an adjunct professor of law at Georgetown Law and an associate scholar in the Center for Global Health at the University of Pennsylvania. He is also a PhD candidate in public international law at Leiden Law School, where he is writing on human rights considerations in international investment law. His other academic engagement includes serving: on the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO); as a contributor to Oxford University Press’ Investment Claims resource; and as a contributor to Harvard Law School’s Bill of Health blog. In the past, he has: taught at The George Washington University (2016-19) and Drexel University (2013-14); and served as an adjunct fellow in the University of Pennsylvania’s Center for Public Health Initiatives (2016-19).
Nick’s work has appeared in law reviews, peer-reviewed journals, and popular media outlets. He has lectured in various academic and industry fora, as well as appeared on U.S. news programs as an expert in public health law. He trained as a lawyer in the U.S., and holds graduate degrees in global health law and bioethics. He resides in Washington, DC.